Healthcare provider profile · identity verified

Rita Albano, MD

Internal Medicine · STATEN ISLAND, NY · NPI 1174587349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	456	195
Losartan Potassium	Losartan Potassium	429	161
Amlodipine Besylate	Amlodipine Besylate	424	162
Metoprolol Succinate	Metoprolol Succinate	308	119
Simvastatin	Simvastatin	289	109
Levothyroxine Sodium	Levothyroxine Sodium	232	82
Metformin Hcl	Metformin Hcl	228	95
Hydrochlorothiazide	Hydrochlorothiazide	168	72
Albuterol Sulfate Hfa	Albuterol Sulfate	160	69
Gabapentin	Gabapentin	153	66
Rosuvastatin Calcium	Rosuvastatin Calcium	153	61
Lisinopril	Lisinopril	114	46
Metoprolol Tartrate	Metoprolol Tartrate	114	46
Allopurinol	Allopurinol	112	36
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	107	35
Eliquis	Apixaban	107	37
Omeprazole	Omeprazole	101	43
Pantoprazole Sodium	Pantoprazole Sodium	97	39
Furosemide	Furosemide	96	42
Tamsulosin Hcl	Tamsulosin Hcl	83	37
Clopidogrel	Clopidogrel Bisulfate	80	34
Ozempic	Semaglutide	79	17
Nifedipine Er	Nifedipine	76	32
Famotidine	Famotidine	73	39
Tizanidine Hcl	Tizanidine Hcl	73	45
Glipizide	Glipizide	70	29
Meloxicam	Meloxicam	68	42
Diclofenac Sodium	Diclofenac Sodium	66	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	31
Trazodone Hcl	Trazodone Hcl	63	25
Atenolol	Atenolol	62	24
Januvia	Sitagliptin Phosphate	59	25
Alendronate Sodium	Alendronate Sodium	57	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	49
Metformin Hcl Er	Metformin Hcl	54	29
Montelukast Sodium	Montelukast Sodium	53	26
Pregabalin	Pregabalin	52	15
Azelastine Hcl	Azelastine Hcl	49	32
Glimepiride	Glimepiride	47	22
Glipizide Er	Glipizide	47	18
Alprazolam	Alprazolam	46	suppressed
Enalapril Maleate	Enalapril Maleate	45	16
Fenofibrate	Fenofibrate Nanocrystallized	45	20
Pravastatin Sodium	Pravastatin Sodium	39	16
Triamcinolone Acetonide	Triamcinolone Acetonide	38	26
Ezetimibe	Ezetimibe	37	18
Vitamin D2	Ergocalciferol (Vitamin D2)	37	14
Azithromycin	Azithromycin	35	33
Fluticasone Propionate	Fluticasone Propionate	35	17
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Janumet	Sitagliptin Phos/Metformin Hcl	33	11
Jardiance	Empagliflozin	33	12
Mirtazapine	Mirtazapine	32	13
Sertraline Hcl	Sertraline Hcl	32	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	31	17
Carvedilol	Carvedilol	31	15
Ibuprofen	Ibuprofen	31	14
Pioglitazone Hcl	Pioglitazone Hcl	29	11
Valsartan	Valsartan	29	11
Donepezil Hcl	Donepezil Hcl	28	11
Farxiga	Dapagliflozin Propanediol	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Ammonium Lactate	Ammonium Lactate	26	suppressed
Cefdinir	Cefdinir	26	25
Finasteride	Finasteride	26	14
Meclizine Hcl	Meclizine Hcl	26	18
Mupirocin	Mupirocin	26	21
Nabumetone	Nabumetone	26	15
Tramadol Hcl	Tramadol Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	11
Xarelto	Rivaroxaban	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Synthroid	Levothyroxine Sodium	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	14
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Levetiracetam	Levetiracetam	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Prednisone	Prednisone	18	13
Baclofen	Baclofen	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	11
Lovastatin	Lovastatin	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Lactulose	Lactulose	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	12	suppressed
Ramipril	Ramipril	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error